British drugs group AstraZeneca and the University of Oxford say their jointly-developed vaccine against COVID-19 has shown “an average efficacy of 70 percent” in trials. “This vaccine’s efficacy and ...
Pfizer PFE and AstraZeneca AZN are two global pharmaceutical leaders with a commanding presence in oncology. For Pfizer, oncology is a key growth driver, accounting for roughly 27% of total company ...
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Wall Street is looking to U.S. drugmaker Eli Lilly and Anglo-Swedish rival AstraZeneca as the potential next in line after Pfizer struck a deal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results